InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (8 ops.)
Browse the detailed record of transactions filed by Thompson Peter A., Director. Insider active across 5 companies, notably Janux Therapeutics, Inc.. Cumulatively, 13 disclosures have been published. Total volume traded: €38.8m. The latest transaction was disclosed on 18 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations13 total
€950,067138,000 shares@ €6.88450.036% mcap100.0% of flow
Common Stock
SEC:0000947871-22-000628:0·
Ideal exit: 12 Feb 2023 (T+270)
€658,44036,700 shares@ €17.94110.078% mcap7.7% of flow
Common Stock
SEC:0000947871-21-001322·
€658,44036,700 shares@ €17.94110.078% mcap3.9% of flow
Common Stock
SEC:0000947871-21-001322:0·
€2m108,300 shares@ €16.84770.22% mcap21.4% of flow
Common Stock
SEC:0000947871-21-001314·
€2m108,300 shares@ €16.84770.22% mcap10.7% of flow
Common Stock
SEC:0000947871-21-001314:0·
€6m356,800 shares@ €16.88990.71% mcap70.8% of flow
Common Stock
SEC:0000947871-21-001300·
€6m356,800 shares@ €16.88990.71% mcap35.4% of flow
Common Stock
SEC:0000947871-21-001300:0·
€6m1,109,644 shares@ €5.1917100.0% of flow
Common Stock, $0.0001 par value
SEC:0000947871-21-001016·
€6m1,109,644 shares@ €5.19170.56% mcap50.0% of flow
Common Stock, $0.0001 par value
SEC:0000947871-21-001016:0·
€5m585,106 shares@ €7.9881100.0% of flow
Common Stock
SEC:0000947871-21-001009·
Ideal exit: 14 Jun 2022 (T+270)
€5m585,106 shares@ €7.988150.0% of flow
Common Stock
SEC:0000947871-21-001009:0·
Ideal exit: 14 Jun 2022 (T+270)
1,348,421 shares
Common Stock
SEC:0001209191-21-041058·
1,348,421 shares
Common Stock
SEC:0001209191-21-041058:0·
13 of 13 declarations
About Thompson Peter A.
Peter A. Thompson is a Board Member at Janux Therapeutics, Inc., Alpine Immune Sciences, Inc., and Corvus Pharmaceuticals, Inc. He plays a key role in the governance of these companies, bringing his expertise in strategy and business development. Thompson is involved in overseeing performance and growth initiatives, thereby contributing to the achievement of organizational goals.
